Circulating Angiogenic Cells and Alzheimer’s Disease: Contribution of the Bone Marrow to Pathogenesis of the Disease

Por Sadowski, Martin J.
Publicado em 2010

Prominent Neuroleptic Sensitivity in a Case of Early-onset Alzheimer Disease due to Presenilin-1 G206A Mutation

Por Cercy, Steven P., Sadowski, Martin J., Wisniewski, Thomas
Publicado no Cogn Behav Neurol (2008)

Differential Molecular Chaperone Response Associated with Various Mouse Adapted Scrapie Strains

Por Asuni, Ayodeji A., Pankiewicz, Joanna E., Sadowski, Martin J.
Publicado em 2013

Reply to Greig et al. “Amyloid precursor protein synthesis inhibitors for Alzheimer’s disease treatment”

Por Asuni, Ayodeji A., Pankiewicz, Joanna E., Sadowski, Martin J.
Publicado no Ann Neurol (2014)

Antioxidant Peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo

Por Asuni, Ayodeji. A., Guridi, Maitea, Sanchez, Sandrine, Sadowski, Martin J
Publicado no Neurochem Int (2015)

In vivo hippocampal microdialysis reveals impairment of NMDA receptor–cGMP signaling in APP(SW) and APP(SW)/PS1(L166P) Alzheimer's transgenic mice

Por Duszczyk, Malgorzata, Kuszczyk, Magdalena, Guridi, Maitea, Lazarewicz, Jerzy W., Sadowski, Martin J.
Publicado em 2012

1MeTIQ provides protection against Aβ-induced reduction of surface expression of synaptic proteins and inhibits H(2)O(2)-induced oxidative stress in primary hippocampal neurons

Por Kuszczyk, Magdalena A., Sadowski, Martin J., Antkiewicz-Michaluk, Lucyna, Lazarewicz, Jerzy W.
Publicado em 2013

Modulation of APP Expression Reduces Aβ Deposition in a Mouse Model

Por Asuni, Ayodeji A., Guridi, Maitea, Pankiewicz, Joanna E., Sanchez, Sandrine, Sadowski, Martin J.
Publicado no Ann Neurol (2014)

Blocking the apolipoprotein E/amyloid-β interaction as a potential therapeutic approach for Alzheimer's disease

Por Sadowski, Martin J., Pankiewicz, Joanna, Scholtzova, Henrieta, Mehta, Pankaj D., Prelli, Frances, Quartermain, David, Wisniewski, Thomas
Publicado em 2006

Anti-PrP Mab 6D11 suppresses PrP(Sc) replication in prion infected myeloid precursor line FDC-P1/22L and in the lymphoreticular system in vivo

Por Sadowski, Martin J., Pankiewicz, Joanna, Prelli, Frances, Scholtzova, Henrieta, Spinner, Daryl S., Kascsak, Regina B., Kascsak, Richard J., Wisniewski, Thomas
Publicado em 2009

Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice

Por Pankiewicz, Joanna E, Guridi, Maitea, Kim, Jungsu, Asuni, Ayodeji A, Sanchez, Sandrine, Sullivan, Patrick M, Holtzman, David M, Sadowski, Martin J
Publicado em 2014

APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice

Por Pankiewicz, Joanna E, Baquero-Buitrago, Jairo, Sanchez, Sandrine, Lopez-Contreras, Jennifer, Kim, Jungsu, Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J.
Publicado no Mol Neurodegener (2017)

Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration

Por Kuszczyk, Magdalena A., Sanchez, Sandrine, Pankiewicz, Joanna, Kim, Jungsu, Duszczyk, Malgorzata, Guridi, Maitea, Asuni, Ayodeji A., Sullivan, Patrick M., Holtzman, David M., Sadowski, Martin J.
Publicado em 2013

The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer’s disease

Por Glodzik-Sobanska, Lidia, Pirraglia, Elizabeth, Brys, Miroslaw, de Santi, Susan, Mosconi, Lisa, Rich, Kenneth E., Switalski, Remigiusz, Saint Louis, Leslie, Sadowski, Martin J., Martiniuk, Frank, Mehta, Pankaj, Pratico, Domenico, Zinkowski, Raymond P., Blennow, Kaj, de Leon, Mony J.
Publicado em 2007